van Ravesteyn NT, van Lier L, Schechter CB, Ekwueme DU, Royalty J, Miller JW, et al. Transition from film to digital mammography: impact for breast cancer screening through the national breast and cervical cancer early detection program. Am J Prev Med. 2015;48(5):535–42.
Hopper JL, Nguyen TL, Schmidt DF, Makalic E, Song YM, Sung J, et al. Going beyond conventional mammographic density to discover novel mammogram-based predictors of breast cancer risk. J Clin Med. 2020;9(3):627.
Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599–614.
Siu AL, Force USPST. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164(4):279–96.
Qaseem A, Lin JS, Mustafa RA, Horwitch CA, Wilt TJ, Clinical Guidelines Committee of the American College of P, et al. Screening for breast cancer in average-risk women: a guidance statement from the American College of Physicians. Ann Intern Med. 2019;170(8):547–60.
Bevers TB, Ward JH, Arun BK, Colditz GA, Cowan KH, Daly MB, et al. Breast cancer risk reduction, Version 2.2015. J Natl Compr Cancer Netw. 2015;13(7):880–915.
Louro J, Posso M, Hilton Boon M, Roman M, Domingo L, Castells X, et al. A systematic review and quality assessment of individualised breast cancer risk prediction models. Br J Cancer. 2019;121(1):76–85.
Brooks JD, Nabi HH, Andrulis IL, Antoniou AC, Chiquette J, Despres P, et al. Personalized risk assessment for prevention and early detection of breast cancer: integration and implementation (PERSPECTIVE I&I). J Pers Med. 2021;11(6):511.
Jiang S, Cao J, Rosner B, Colditz G. Supervised two-dimensional functional principal component analysis with time-to-event outcomes and mammogram imaging data. Biometrics. 2021.
Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, et al. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol. 2020;17(11):687–705.
Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356(3):227–36.
Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005;6(10):798–808.
Ray KM, Price ER, Joe BN. Breast density legislation: mandatory disclosure to patients, alternative screening, billing, reimbursement. AJR Am J Roentgenol. 2015;204(2):257–60.
Bae JM, Kim EH. Breast density and risk of breast cancer in asian women: a meta-analysis of observational studies. J Prev Med Public Health. 2016;49(6):367–75.
Chiu SY, Duffy S, Yen AM, Tabar L, Smith RA, Chen HH. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomark Prev. 2010;19(5):1219–28.
Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, Lajous M, et al. Mammographic density and ageing: a collaborative pooled analysis of cross-sectional data from 22 countries worldwide. PLoS Med. 2017;14(6):e1002335.
Soguel L, Diorio C. Anthropometric factors, adult weight gain, and mammographic features. Cancer Causes Control. 2016;27(3):333–40.
Yaffe MJ. Mammographic density. Measurement of mammographic density. Breast Cancer Res. 2008;10(3):209.
Kaufhold J, Thomas J, Eberhard J, Galbo C, Trotter DG. A calibration approach to glandular tissue composition estimation in digital mammography. Med Phys. 2002;29(8):1867–80.
Wolfe JN. Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol. 1976;126(6):1130–7.
Gastounioti A, Conant EF, Kontos D. Beyond breast density: a review on the advancing role of parenchymal texture analysis in breast cancer risk assessment. Breast Cancer Res. 2016;18(1):91.
Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation. 2010;121(15):1768–77.
Lloyd-Jones DM, Liu K, Tian L, Greenland P. Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med. 2006;145(1):35–42.
Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280–6.
Abdolell M, Payne JI, Caines J, Tsuruda K, Barnes PJ, Talbot PJ, et al. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening. Eur Radiol. 2020;30(10):5417–26.
Ali MA, Czene K, Eriksson L, Hall P, Humphreys K. Breast tissue organisation and its association with breast cancer risk. Breast Cancer Res. 2017;19(1):103.
Azam S, Eriksson M, Sjolander A, Gabrielson M, Hellgren R, Czene K, et al. Mammographic microcalcifications and risk of breast cancer. Br J Cancer. 2021;125:759–65.
Choi WJ, Cha JH, Kim HH, Shin HJ, Chae EY. Analysis of prior mammography with negative result in women with interval breast cancer. Breast Cancer. 2016;23(4):583–9.
Eriksson M, Czene K, Pawitan Y, Leifland K, Darabi H, Hall P. A clinical model for identifying the short-term risk of breast cancer. Breast Cancer Res. 2017;19(1):29.
Evans KK, Culpan AM, Wolfe JM. Detecting the “gist” of breast cancer in mammograms three years before localized signs of cancer are visible. Br J Radiol. 2019;92(1099):20190136.
Gastounioti A, Hsieh MK, Cohen E, Pantalone L, Conant EF, Kontos D. Incorporating breast anatomy in computational phenotyping of mammographic parenchymal patterns for breast cancer risk estimation. Sci Rep. 2018;8(1):17489.
Heidari M, Khuzani AZ, Hollingsworth AB, Danala G, Mirniaharikandehei S, Qiu Y, et al. Prediction of breast cancer risk using a machine learning approach embedded with a locality preserving projection algorithm. Phys Med Biol. 2018;63(3):035020.
Heine J, Fowler E, Scott CG, Jensen MR, Shepherd J, Hruska CB, et al. Mammographic variation measures, breast density, and breast cancer risk. AJR Am J Roentgenol. 2021;217(2):326–35.
Hsu W, Zhou X, Petruse A, Chau N, Lee-Felker S, Hoyt A, et al. Role of clinical and imaging risk factors in predicting breast cancer diagnosis among BI-RADS 4 cases. Clin Breast Cancer. 2019;19(1):e142–51.
Kontos D, Winham SJ, Oustimov A, Pantalone L, Hsieh MK, Gastounioti A, et al. Radiomic phenotypes of mammographic parenchymal complexity: toward augmenting breast density in breast cancer risk assessment. Radiology. 2019;290(1):41–9.
Ma L, Cai Y, Lin X, He Z, Zeng H, Chen W, Qin G. Association of the differences in average glandular dose with breast cancer risk. BioMed Res Int. 2020;2020:8943659.
Li T, Tang L, Gandomkar Z, Heard R, Mello-Thoms C, Shao Z, et al. Mammographic density and other risk factors for breast cancer among women in China. Breast J. 2018;24(3):426–8.
Malkov S, Shepherd JA, Scott CG, Tamimi RM, Ma L, Bertrand KA, et al. Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status. Breast Cancer Res. 2016;18(1):122.
Perez-Benito FJ, Signol F, Perez-Cortes JC, Pollan M, Perez-Gomez B, Salas-Trejo D, et al. Global parenchymal texture features based on histograms of oriented gradients improve cancer development risk estimation from healthy breasts. Comput Methods Programs Biomed. 2019;177:123–32.
Schmidt DF, Makalic E, Goudey B, Dite GS, Stone J, Nguyen TL, et al. Cirrus: an automated mammography-based measure of breast cancer risk based on textural features. JNCI Cancer Spectr. 2018;2(4):pky057.
Sorin V, Yagil Y, Shalmon A, Gotlieb M, Faermann R, Halshtok-Neiman O, et al. Background parenchymal enhancement at contrast-enhanced spectral mammography (CESM) as a breast cancer risk factor. Acad Radiol. 2020;27(9):1234–40.
Tagliafico AS, Valdora F, Mariscotti G, Durando M, Nori J, La Forgia D, et al. An exploratory radiomics analysis on digital breast tomosynthesis in women with mammographically negative dense breasts. Breast. 2018;40:92–6.
Tan M, Zheng B, Leader JK, Gur D. Association Between changes in mammographic image features and risk for near-term breast cancer development. IEEE Trans Med Imaging. 2016;35(7):1719–28.
Tan M, Mariapun S, Yip CH, Ng KH, Teo SH. A novel method of determining breast cancer risk using parenchymal textural analysis of mammography images on an Asian cohort. Phys Med Biol. 2019;64(3):035016.
Wang C, Brentnall AR, Cuzick J, Harkness EF, Evans DG, Astley S. A novel and fully automated mammographic texture analysis for risk prediction: results from two case–control studies. Breast Cancer Res. 2017;19(1):114.
Ward L, Heller S, Hudson S, Wilkinson L. Parenchymal pattern in women with dense breasts. Variation with age and impact on screening outcomes: observations from a UK screening programme. Eur Radiol. 2018;28(11):4717–24.
Warner ET, Rice MS, Zeleznik OA, Fowler EE, Murthy D, Vachon CM, et al. Automated percent mammographic density, mammographic texture variation, and risk of breast cancer: a nested case–control study. NPJ Breast Cancer. 2021;7(1):68.
Winkel RR, Euler-Chelpin MV, Lynge E, Diao P, Lillholm M, Kallenberg M, et al. Risk stratification of women with false-positive test results in mammography screening based on mammographic morphology and density: a case control study. Cancer Epidemiol. 2017;49:53–60.
Winkel RR, von Euler-Chelpin M, Nielsen M, Petersen K, Lillholm M, Nielsen MB, et al. Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: a case–control study. BMC Cancer. 2016;16(1):414.
Yan S, Wang Y, Aghaei F, Qiu Y, Zheng B. Improving performance of breast cancer risk prediction by incorporating optical density image feature analysis: an assessment. Acad Radiol. 2022;29(Suppl 1):S199–210.
Yan S, Wang Y, Aghaei F, Qiu Y, Zheng B. Applying a new bilateral mammographic density segmentation method to improve accuracy of breast cancer risk prediction. Int J Comput Assist Radiol Surg. 2017;12(10):1819–28.
Pertuz S, Sassi A, Holli-Helenius K, Kämäräinen J, Rinta-Kiikka I, Lääperi AL, Arponen O. Clinical evaluation of a fully-automated parenchymal analysis software for breast cancer risk assessment: A pilot study in a Finnish sample. Eur J Radiol. 2019;121:108710.
Brentnall AR, Cuzick J, Buist DS, Bowles EJA. Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density. JAMA Oncol. 2018;4(9):e180174.
Evans DGR, Donnelly LS, Harkness EF, Astley SM, Stavrinos P, Dawe S, et al. Breast cancer risk feedback to women in the UK NHS breast screening population. Br J Cancer. 2016;114(9):1045–52.
Brentnall AR, Harkness EF, Astley SM, Donnelly LS, Stavrinos P, Sampson S, et al. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort. Breast Cancer Res. 2015;17(1):147.
Visvanathan K, Fabian CJ, Bantug E, Brewster AM, Davidson NE, DeCensi A, et al. Use of endocrine therapy for breast cancer risk reduction: ASCO clinical practice guideline update. J Clin Oncol. 2019;37(33):3152–65.
Gastounioti A, Desai S, Ahluwalia VS, Conant EF, Kontos D. Artificial intelligence in mammographic phenotyping of breast cancer risk: a narrative review. Breast Cancer Res. 2022;24(1):14.
Gao J, Warren R, Warren-Forward H, Forbes JF. Reproducibility of visual assessment on mammographic density. Breast Cancer Res Treat. 2008;108(1):121–7.
Pettersson A, Graff RE, Ursin G, Santos Silva ID, McCormack V, Baglietto L, et al. Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. 2014;106(5):dju078.
Dench E, Bond-Smith D, Darcey E, Lee G, Aung YK, Chan A, et al. Measurement challenge: protocol for international case–control comparison of mammographic measures that predict breast cancer risk. BMJ Open. 2019;9(12):e031041.
Buda M, Saha A, Walsh R, Ghate S, Li N, Swiecicki A, et al. A data set and deep learning algorithm for the detection of masses and architectural distortions in digital breast tomosynthesis images. JAMA Netw Open. 2021;4(8):e2119100.
Pace LE, Keating NL. Should women at lower-than-average risk of breast cancer undergo less frequent screening? J Natl Cancer Inst. 2021;113(8):953–4.
Pertuz S, Sassi A, Karivaara-Mäkelä M, Holli-Helenius K, Lääperi A-L, Rinta-Kiikka I, et al. Micro-parenchymal patterns for breast cancer risk assessment. Biomed Phys Eng Express. 2019;5(6):065008.